Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:36 PM
Ignite Modification Date:
2025-12-24 @ 6:36 PM
NCT ID:
NCT05186857
Eligibility Criteria:
Patients Patients receiving an allotransplant at participating hospitals during the study period before initiating conditioning period.
Inclusion Criteria:
* Patients of any age who will receive allogeneic hematopoietic transplantation of any modality with any diagnosis.
* Agreement of the patient to participate by signing the informed consent or his/her legal representatives/assent (if applicable).
Exclusion Criteria
\- Allotransplant recipients in stages after the initial pre-conditioning.
Donors
Family donors from patients included in the study:
Inclusion criteria:
* Agreement of the donor to participate by signing the informed consent or his/her legal representatives/assent (if applicable).
* Donor relatives with any degree of identity in the Human Leukocyte Antigens (HLA).
Exclusion Criteria:
* Unrelated donors
* Transplants from umbilical cord blood source.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
100 Years
Study:
NCT05186857
Study Brief:
Protocol Section:
NCT05186857